AU7283374A - Amphetamine derivatives - Google Patents

Amphetamine derivatives

Info

Publication number
AU7283374A
AU7283374A AU72833/74A AU7283374A AU7283374A AU 7283374 A AU7283374 A AU 7283374A AU 72833/74 A AU72833/74 A AU 72833/74A AU 7283374 A AU7283374 A AU 7283374A AU 7283374 A AU7283374 A AU 7283374A
Authority
AU
Australia
Prior art keywords
amphetamine derivatives
amphetamine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU72833/74A
Other versions
AU491359B2 (en
Inventor
Svante Bertil Ross
Sven-Ove Ogren
Gosta Lennart Florvall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
Original Assignee
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE7312001A external-priority patent/SE382047B/en
Application filed by Astra Lakemedel AB filed Critical Astra Lakemedel AB
Application granted granted Critical
Publication of AU491359B2 publication Critical patent/AU491359B2/en
Publication of AU7283374A publication Critical patent/AU7283374A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
AU72833/74A 1973-09-04 1974-08-30 Amphetamine derivatives Expired AU491359B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SESE7312002 1973-09-04
SE7312001A SE382047B (en) 1973-09-04 1973-09-04 PROCEDURE FOR THE PREPARATION OF 4-AMINOAMPHETAMINE DERIVATIVES

Publications (2)

Publication Number Publication Date
AU491359B2 AU491359B2 (en) 1976-03-04
AU7283374A true AU7283374A (en) 1976-03-04

Family

ID=

Also Published As

Publication number Publication date
NO139408B (en) 1978-11-27
JPS5050329A (en) 1975-05-06
IE40514B1 (en) 1979-06-20
GB1461667A (en) 1977-01-19
FI62281C (en) 1982-12-10
CA1051436A (en) 1979-03-27
NO142624C (en) 1980-09-17
LU70852A1 (en) 1975-06-11
JPS5835177B2 (en) 1983-08-01
FR2242079A1 (en) 1975-03-28
ATA702574A (en) 1976-09-15
FR2242079B1 (en) 1978-07-21
FI257674A (en) 1975-03-05
AT336566B (en) 1977-05-10
DK139716C (en) 1979-09-17
DK139716B (en) 1979-04-02
IE40514L (en) 1975-03-04
NL7411753A (en) 1975-03-06
NO142624B (en) 1980-06-09
NO791507L (en) 1975-03-05
CH603547A5 (en) 1978-08-31
DE2440734A1 (en) 1975-03-13
US3996381A (en) 1976-12-07
DK464774A (en) 1975-05-05
NO139408C (en) 1979-03-07
HK75778A (en) 1979-01-05
NO743177L (en) 1975-04-01
FI62281B (en) 1982-08-31
CH599106A5 (en) 1978-05-12
DE2440734C2 (en) 1985-01-24
BE819515A (en) 1975-03-04

Similar Documents

Publication Publication Date Title
AU468242B2 (en) 2-cyclohexene-1-one derivatives
AU474137B2 (en) Auto-refractometer
CA1020171A (en) 2-methylbenzamide derivatives
AU468964B2 (en) Melik
CA1025856A (en) Quinoline-3-carboxamidotetrazole derivatives
CA1029036A (en) Octahydro-acetonaphthone derivatives
CA1018170A (en) Lactamimide derivatives
CA1019749A (en) Beneoxazolinone derivatives
CA1016181A (en) Substituted pyrrolidinemethanols
AU472907B2 (en) Firecheck
HK75778A (en) Amphetamine derivatives
CA1034943A (en) Substituted phenylglycylcephalosporins
CA1026331A (en) Substituted indolobenzazepines
CA1022943A (en) Substituted ureido-s-triazines
AU491359B2 (en) Amphetamine derivatives
AU458655B2 (en) Benzenesulfonylurea derivatives
CA1024154A (en) Nor-sesquiterpene derivatives
AU471241B2 (en) Benzothiazolylureas
AU482770B2 (en) 4-deoxy-4-oxoerythromycin b derivatives
CA1007249A (en) 4-alkoxy-4-phenylcyclohexylamine derivatives
AU487016B2 (en) Debenzocycoheptene derivatives
AU470521B2 (en) 5-benzyl-pyrimidine derivatives
AU480266B2 (en) 4-o-sulfonyl erythromycin-9-o-oxime derivatives
AU479187B2 (en) Triazolobenzoidiazepine derivatives
CA1002947A (en) Imidazo-benzodiazepine derivatives